Linear Capital Perspective | GPT Is a Pandora's Box or Aladdin's Lamp, Depending on Human Understanding and Action on Technology
We think of ChatGPT as a genie lamp that you can ask endless questions of.
Articles
A Visit to a Dalton Venture Family Company | Heyuan Bio's Lulu Lyu: China's Homegrown CAR-T Therapy Is About to Become Reality, Bringing New Hope for Relapsed or Refractory Acute Lymphoblastic Leukemia Patients
"After nearly five years, He Yuan Bio's first core product, inaticabtagene autoleucel injection, has treated more than 100 Chinese patients in clinical studies for acute lymphoblastic leukemia — representing the largest accumulated dataset to date on CD19 CAR-T clinical safety and efficacy in a Chinese patient population."
Dalton Venture's Sun Qi: Prioritize Hard-Tech Sectors That Serve National Needs, Prioritize Solving Supply Chain Security Issues | Dalton Insights
At the "2023 China Investment Annual Conference" summit, Sun Qi shared his perspectives and experience with fellow guests on the topic of *How Much Longer Is the Window for Domestic Substitution in Medical Devices?*
Luchen Tech Closes Series A Financing of Hundreds of Millions of RMB to Build Distributed AI Development and Deployment Platform | BlueRun Ventures
Lowering the Barrier to Deploying Large Language Models
In the long winter of consumption, Hongshan wants to snap its fingers and find resonance.
Sparks mark the beginning of the next cycle.
Xiaoman (Grain Buds) — the eighth of the 24 solar terms, typically falling around May 20–22, when grain crops begin to plump but are not yet fully ripe.
Oasis Capital is a new-generation venture capital firm in China, dedicated to discovering the most vital entrepreneurs of the next decade and growing alongside them to create long-term value. "Celebrating Vitality" is Oasis Capital's vision and mission. This vitality — what the firm calls *Vitality* — is both the direction of structural transformation in the era and the force of resilience and evolution within entrepreneurs themselves.
Oasis Capital won Diyixinsheng's Q1 2023 awards for "Most Active Venture Capital Firm" and "Most Active Investor in Enterprise Services."
Diyixinsheng continues to focus on early-stage investment institutions, venture capital firms, private equity investors, financial advisors, and LPs in the primary market, and has invited Tianyancha and IT Juzi as data partners to produce the Invest in China — 2023 Q1 Most Active Chinese Institutions series, creating what it calls "a true founder's guide to fundraising and an LP's reference for investment."
Oasis Capital Named to ChinaVenture's "Best Early-Stage VC Firms of 2022" Top 30
ChinaVenture has published the "ChinaVenture Rankings" — a series of lists covering China's venture capital and private equity investment institutions — for 17 consecutive years as an independent third-party organization. Drawing on CVSource data and standardized by ChinaVenture Research Institute, the rankings are compiled based on overall point totals and cover more than 1,000 active investment institutions in the private equity space. Known for its rigorous categorization criteria, the list is recognized for its professionalism, authority, and exacting standards, and is widely regarded as a domestic
Linear Capital received honors including "Top 8 Best Early-Stage VC Firms" and "Best Investment Firm in China's AI and Big Data Industry" from ChinaVenture.
On May 19, ChinaVenture released its 2022 annual rankings of Chinese venture capital and private equity investment institutions — the ChinaVenture Awards. **Linear Capital was named among the "Top 8 Best Early-Stage VC Firms in China" and received the "Top 20 Best Investment Firms in China's AI and Big Data Sector" award, among other honors**.
Yunqi Capital Repeats as Top 5 Early-Stage VC in China at CV Awards, Among Other Honors | Yunqi News
Technological Innovation Powers Industrial Development